
Taiho Oncology Presents Data At The 2025 American Society Of Clinical Oncology Annual Meeting
(MENAFN- PR Newswire) Data will be shared in two oral presentations, a poster and two online abstracts Highlights include a potential novel, all-oral therapy for AML; and Phase 2 data for a novel treatment targeting NSCLC that harbors EGFR exon 20 …